Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03462342
Title Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer (CAPRI)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Pennsylvania
Indications

ovarian serous carcinoma

fallopian tube cancer

peritoneal carcinoma

Therapies

AZD6738 + Olaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.